Mise en place d’un workflow pour l’étude pharmacogénétique des antivitamines K
| dc.contributor.advisor | N. MESSAOUDI | |
| dc.contributor.author | Christiana Philippa Linanipo NAHM-TCHOUGLI | |
| dc.date.accessioned | 2023-09-15T13:41:24Z | |
| dc.date.accessioned | 2026-01-22T13:33:18Z | |
| dc.date.available | 2023-09-15T13:41:24Z | |
| dc.date.issued | 2019 | |
| dc.description.collaborator | A. IBRAHIMI | |
| dc.description.collaborator | N. EL HAFIDI | |
| dc.description.collaborator | Z. LAKHAL | |
| dc.description.collaborator | Y. BOUSLIMAN | |
| dc.identifier.uri | https://toubkal.imist.ma/handle/123456789/19032 | |
| dc.identifier.uri | https://doi.org/10.83129/toubkal-7857 | |
| dc.language.iso | fr | |
| dc.publisher | Université Mohammed 5 de Rabat, Faculté de Médecine et de Pharmacie, Rabat | fr_FR |
| dc.subject | Pharmacogénétique | fr_FR |
| dc.subject | PCR-RFLP | fr_FR |
| dc.subject | Optimisation | fr_FR |
| dc.subject | Antivitamines K | fr_FR |
| dc.subject | SNP | fr_FR |
| dc.subject.other | Sciences médicales | |
| dc.subject.specific | Pharmacogénétique | |
| dc.title | Mise en place d’un workflow pour l’étude pharmacogénétique des antivitamines K | fr_FR |
Files
Original bundle
1 - 1 of 1